|
[1]
|
Myers, J.A. and Miller, J.S. (2021) Exploring the NK Cell Platform for Cancer Immunotherapy. Nature Reviews. Clinical Oncology, 18, 85-100. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chidambaranathan-Reghupaty, S., Fisher, P.B. and Sarkar, D. (2021) Hepatocellular Carcinoma (HCC): Epidemiology, Etiology and Molecular Classification. Ad-vances in Cancer Research, 149, 1-61. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Llovet, J.M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M. and Gores, G. (2016) Hepatocellular Carcinoma. Nature Reviews. Disease Primers, 2, Article No. 16018. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Sangro, B., Sarobe, P., Hervás-Stubbs, S. and Melero, I. (2021) Advances in Immunotherapy for Hepatocellular Carcinoma. Nature Reviews. Gastroenterology & Hepatology, 18, 525-543. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Sas, Z., Cendrowicz, E., Weinhäuser, I. and Rygiel, T.P. (2022) Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. International Journal of Molecular Sciences, 23, Article No. 3778. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Liu, P., Chen, L. and Zhang, H. (2018) Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy. Journal of Immunology Research, 2018, Article ID: 1206737. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Prager, I. and Watzl, C. (2019) Mechanisms of Natural Killer Cell-Mediated Cellular Cytotoxicity. Journal of Leukocyte Biology, 105, 1319-1329. [Google Scholar] [CrossRef]
|
|
[8]
|
Jiang, W., Zhang, C., Tian, Z. and Zhang, J. (2013) hIFN-α Gene Modification Augments Human Natural Killer Cell Line Anti-Human Hepatocellular Carcinoma Function. Gene Therapy, 20, 1062-1069. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zhang, C., Hu, Y. and Shi, C. (2020) Targeting Natural Killer Cells for Tumor Immunotherapy. Frontiers in Immunology, 11, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bassani, B., Baci, D., Gallazzi, M., Poggi, A., Bruno, A. and Mortara, L. (2019) Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects. Cancers, 11, Article No. 461. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Sun, C., Sun, H.Y., Xiao, W.H., Zhang, C. and Tian, Z.G. (2015) Natural Killer Cell Dysfunction in Hepatocellular Carcinoma and NK Cell-Based Immunotherapy. Acta Pharmacologica Sinica, 36, 1191-1199. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yu, L., Liu, X., Wang, X., Yan, F., Wang, P., Jiang, Y., Du, J. and Yang, Z. (2021) TIGIT(+) TIM-3(+) NK Cells Are Correlated with NK Cell Exhaustion and Disease Progression in Patients with Hepatitis B Virus‑Related Hepatocellular Carcinoma. Oncoimmunology, 10, Article ID: 1942673. [Google Scholar] [CrossRef]
|
|
[13]
|
Zecca, A., Barili, V., Olivani, A., Biasini, E., Boni, C., Fisicaro, P., Montali, I., Tiezzi, C., Dalla Valle, R., Ferrari, C., Cariani, E. and Missale, G. (2022) Targeting Stress Sen-sor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer. Frontiers in Immunology, 13, Article ID: 875072. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mantovani, S., Oliviero B., Varchetta, S., Mele, D. and Mondelli, M.U. (2020) Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Ap-proaches. Cancers, 12, Article No. 926. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Liu, D., Tian, S., Zhang, K., Xiong, W., Lubaki, N.M., Chen, Z. and Han, W. (2017) Chimeric Antigen Receptor (CAR)-Modified Natural Killer Cell-Based Immunotherapy and Immuno-logical Synapse Formation in Cancer and HIV. Protein & Cell, 8, 861-877. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Tseng, H.C., Xiong, W., Badeti, S., Yang, Y., Ma, M., Liu, T., et al. (2020) Efficacy of Anti-CD147 Chimeric Antigen Receptors Targeting Hepatocellular Carcinoma. Nature Communi-cations, 11, Article No. 4810. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomata-ram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sexton, R.E., Al Hallak, M.N., Diab, M. and Azmi, A.S. (2020) Gastric Cancer: A Comprehensive Review of Current and Future Treatment Strategies. Cancer Metastasis Reviews, 39, 1179-1203. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Li, Y., He, X., Fan, L., Zhang, X., Xu, Y. and Xu, X. (2021) Identification of a Novel Immune Prognostic Model in Gastric Cancer. Clinical & Translational Oncology: Official Pub-lication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 23, 846-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, F., Lau, J.K.C. and Yu, J. (2021) The Role of Natural Killer Cell in Gastrointestinal Cancer: Killer or Helper. Oncogene, 40, 717-730. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Mimura, K., Kamiya, T., Shiraishi, K., Kua, L.F., Shabbir, A., So, J., et al. (2014) Therapeutic Potential of Highly Cytotoxic Natural Killer Cells for Gastric Cancer. International Journal of Cancer, 135, 1390-1398. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Lanier, L.L., Yu, G. and Phillips, J.H. (1989) Co-Association of CD3 Zeta with a Receptor (CD16) for IgG Fc on Human Natural Killer Cells. Nature, 342, 803-805. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Xia, P. and Xu, X.Y. (2017) DKK3 Attenuates the Cytotoxic Effect of Nat-ural Killer Cells on CD133(+) Gastric Cancer Cells. Molecular Carcinogenesis, 56, 1712-1721. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Guo, S., Huang, C., Han, F., Chen, B., Ding, Y., Zhao, Y., et al. (2021) Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth. Stem Cells International, 2021, Article ID: 9989790. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Liu, Y., Cheng, Y., Xu, Y., Wang, Z., Du, X., Li, C., et al. (2017) Increased Expression of Programmed Cell Death Protein 1 on NK Cells Inhibits NK-Cell-Mediated Anti-Tumor Function and Indicates Poor Prognosis in Digestive Cancers. Onco-gene, 36, 6143-6153. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Ishikawa, T., Okayama, T., Sakamoto, N., Ideno, M., Oka, K., Enoki, T., et al. (2018) Phase I Clinical Trial of Adoptive Transfer of Expanded Natural Killer Cells in Combination with IgG1 Antibody in Patients with Gastric or Colorectal Cancer. International Journal of Cancer, 142, 2599-2609. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., Padala, S.A. and Barsouk, A. (2020) Epidemiology of Bladder Cancer. Medical Sciences (Basel, Switzerland), 8, 11-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Ranti, D., Bieber, C., Wang, Y.S., Sfakianos, J.P. and Horowitz, A. (2022) Natural Killer Cells: Unlocking New Treatments for Bladder Cancer. Trends in Cancer, 8, 698-710. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Yoon, S.R., Kim, T.D. and Choi, I. (2015) Understanding of Molecular Mechanisms in Natural Killer Cell Therapy. Experimental & Molecular Medicine, 47, e141. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Cao, X., Cai, S.F., Fehniger, T.A., Song, J., Collins, L.I., Piwni-ca-Worms, D.R. and Ley, T.J. (2007) Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppres-sion of Tumor Clearance. Immunity, 27, 635-646. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Mitchison, T.J. (2021) So Many Ways to Naturally Kill a Can-cer Cell. BMC Biology, 19, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Brandau, S., Riemensberger, J., Jacobsen, M., Kemp, D., Zhao, W., Zhao, X., Jocham, D., Ratliff, T.L. and Böhle, A. (2001) NK Cells Are Essential for Effective BCG Immunotherapy. International Journal of Cancer, 92, 697-702. [Google Scholar] [CrossRef]
|
|
[33]
|
Pettenati, C. and Inger-soll, M.A. (2018) Mechanisms of BCG Immunotherapy and Its Outlook for Bladder Cancer. Nature Reviews. Urology, 15, 615-625. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Cao, Y., Wang, X., Jin, T., Tian, Y., Dai, C., Widarma, C., Song, R. and Xu, F. (2020) Immune Checkpoint Molecules in Natural Killer Cells as Potential Targets for Cancer Immunotherapy. Signal Transduction and Targeted Therapy, 5, Article No. 250. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Khan, M., Arooj, S. and Wang, H. (2020) NK Cell-Based Im-mune Checkpoint Inhibition. Frontiers in Immunology, 11, Article No. 167. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., et al. (2019) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 5, 1749-1768. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Thai, A.A., Solomon, B.J., Sequist, L.V., Gainor, J.F. and Heist, R.S. (2021) Lung Cancer. The Lancet (London, England), 398, 535-554. [Google Scholar] [CrossRef]
|
|
[38]
|
Kim, J., Lee, H. and Huang, B.W. (2022) Lung Cancer: Di-agnosis, Treatment Principles, and Screening. American Family Physician, 105, 487-494.
|
|
[39]
|
Mian, M.F., Lauzon, N.M., Stämpfli, M.R., Mossman, K.L. and Ashkar, A.A. (2008) Impairment of Human NK Cell Cytotoxic Activity and Cytokine Release by Cigarette Smoke. Journal of Leukocyte Biology, 83, 774-784. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Kearley, J., Silver, J.S., Sanden, C., Liu, Z., Berlin, A.A., et al. (2015) Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection. Immunity, 42, 566-579. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Ran, G.H., Lin, Y.Q., Tian, L., Zhang, T., Yan, D.M., Yu, J.H. and Deng, Y.C. (2022) Natural Killer Cell Homing and Trafficking in Tissues and Tumors: From Biology to Application. Signal Transduction and Targeted Therapy, 7, Article No. 205. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Wu, S.Y., Fu, T., Jiang, Y.Z. and Shao, Z.M. (2020) Natural Killer Cells in Cancer Biology and Therapy. Molecular Cancer, 19, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Russell, É., Conroy, M.J. and Barr, M.P. (2022) Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer. Cells, 11, Article No. 605. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Cong, J., Wang, X., Zheng, X., Wang, D., Fu, B., Sun, R., Tian, Z. and Wei, H. (2018) Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Pro-gression. Cell Metabolism, 28, 243-255.e5. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Aktaş, O.N., Öztürk, A.B., Erman, B., Erus, S., Tanju, S. and Di-lege, Ş. (2018) Role of Natural Killer Cells in Lung Cancer. Journal of Cancer Research and Clinical Oncology, 144, 997-1003. [Google Scholar] [CrossRef] [PubMed]
|